All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
XS-0822-YF628 | Anti-Mouse MAdCAM-1 (XW-628) m(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Mouse | XW-628 | Rat | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF629 | Anti-Mouse MAdCAM-1 (XW-629) m(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Mouse | XW-629 | Rat | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-1122-YF628 | Anti-MAdCAM-1 KIR CAR (scFv-KIR2DS2-DAP12, MECA-89), pCDCAR1 | Mouse | MECA-89 | Rat | scFv-KIR2DS2 TM&ICD-2A-DAP12 | Lentiviral vector | T Cell | ||
XS-1122-YF629 | Anti-MAdCAM-1 KIR CAR (scFv-KIR2DS2-DAP12, MECA-367), pCDCAR1 | Mouse | MECA-367 | Rat | scFv-KIR2DS2 TM&ICD-2A-DAP12 | Lentiviral vector | T Cell | ||
XS-1122-YF1548 | Anti-MAdCAM-1 TCR-ABR (scFv-TCRα, MECA-89) CAR Plasmid, pCDCAR1 | Mouse | MECA-89 | Rat | scFv-TCRα | Lentiviral vector | T Cell | ||
XS-1122-YF1549 | Anti-MAdCAM-1 TCR-ABR (scFv-TCRα, MECA-367) CAR Plasmid, pCDCAR1 | Mouse | MECA-367 | Rat | scFv-TCRα | Lentiviral vector | T Cell | ||
XS-1122-YF2468 | Anti-MAdCAM-1 TCR-ABR (scFv-TCRβ, MECA-89) CAR Plasmid, pCDCAR1 | Mouse | MECA-89 | Rat | scFv-TCRβ | Lentiviral vector | T Cell | ||
XS-1122-YF2469 | Anti-MAdCAM-1 TCR-ABR (scFv-TCRβ, MECA-367) CAR Plasmid, pCDCAR1 | Mouse | MECA-367 | Rat | scFv-TCRβ | Lentiviral vector | T Cell | ||
XS-1122-YF3388 | Anti-MAdCAM-1 TCR-ABR (scFv-CD3γ, MECA-89) CAR Plasmid, pCDCAR1 | Mouse | MECA-89 | Rat | scFv-CD3γ | Lentiviral vector | T Cell | ||
XS-1122-YF3389 | Anti-MAdCAM-1 TCR-ABR (scFv-CD3γ, MECA-367) CAR Plasmid, pCDCAR1 | Mouse | MECA-367 | Rat | scFv-CD3γ | Lentiviral vector | T Cell | ||
XS-1122-YF4308 | Anti-MAdCAM-1 TCR-ABR (scFv-CD3δ, MECA-89) CAR Plasmid, pCDCAR1 | Mouse | MECA-89 | Rat | scFv-CD3δ | Lentiviral vector | T Cell | ||
XS-1122-YF4309 | Anti-MAdCAM-1 TCR-ABR (scFv-CD3δ, MECA-367) CAR Plasmid, pCDCAR1 | Mouse | MECA-367 | Rat | scFv-CD3δ | Lentiviral vector | T Cell | ||
XS-1122-YF5228 | Anti-MAdCAM-1 TCR-ABR (scFv-CD3ε, MECA-89) CAR Plasmid, pCDCAR1 | Mouse | MECA-89 | Rat | scFv-CD3ε | Lentiviral vector | T Cell | ||
XS-1122-YF5229 | Anti-MAdCAM-1 TCR-ABR (scFv-CD3ε, MECA-367) CAR Plasmid, pCDCAR1 | Mouse | MECA-367 | Rat | scFv-CD3ε | Lentiviral vector | T Cell | ||
XS-1122-YF6148 | Anti-MAdCAM-1 (MECA-89) h(CD28-CD3ζ) CAR, pAAV | Mouse | MECA-89 | Rat | scFv-CD28-CD3ζ | Adeno-associated viral (AAV) vector | T Cell | ||
XS-1122-YF6149 | Anti-MAdCAM-1 (MECA-367) h(CD28-CD3ζ) CAR, pAAV | Mouse | MECA-367 | Rat | scFv-CD28-CD3ζ | Adeno-associated viral (AAV) vector | T Cell | ||
XS-1122-YF7068 | Anti-MAdCAM-1 (MECA-89) h(41BB-CD3ζ) CAR, pAAV | Mouse | MECA-89 | Rat | scFv-41BB-CD3ζ | Adeno-associated viral (AAV) vector | T Cell | ||
XS-1122-YF7069 | Anti-MAdCAM-1 (MECA-367) h(41BB-CD3ζ) CAR, pAAV | Mouse | MECA-367 | Rat | scFv-41BB-CD3ζ | Adeno-associated viral (AAV) vector | T Cell | ||
XS-1122-YF7988 | Anti-MAdCAM-1 (MECA-89) h(CD28-41BB-CD3ζ) CAR, pAAV | Mouse | MECA-89 | Rat | scFv-CD28-41BB-CD3ζ | Adeno-associated viral (AAV) vector | T Cell | ||
XS-1122-YF7989 | Anti-MAdCAM-1 (MECA-367) h(CD28-41BB-CD3ζ) CAR, pAAV | Mouse | MECA-367 | Rat | scFv-CD28-41BB-CD3ζ | Adeno-associated viral (AAV) vector | T Cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION